Top Markets
#1 Akedo Akedo +55.94%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.75%
#4 Velvet Velvet +37.74%
#5 Black Phoenix Black Phoenix +34.04%
#6 Cross Cross +26.84%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.05%
#8 QANplatform QANplatform +14.33%
#9 Bitway Bitway +14.30%
#10 Perle Perle +13.38%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Rangering i aksjer #38547
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Aksjekurs
$0.8
Sist synkronisert: 2023-10-03
Markedsverdi
$922.40K
Endring (1 dag)
-5.88%
Endring (1 år)
0.00%
Land
IL
Handel BiondVax Pharmaceuticals Ltd. (BVXV)

Kategori

Healthcare
Inntekter for BiondVax Pharmaceuticals Ltd. (BVXV)
Inntekter i 2026 TTM: 0
Ifølge BiondVax Pharmaceuticals Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for BiondVax Pharmaceuticals Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE